Hompland Ivar, Fauske Lena, Lorem Geir Fagerjord, Bruland Øyvind S
1Department of Oncology, Norwegian Radium Hospital, Oslo University Hospital, Nydalen, P.O. Box 4953, Oslo, 0424 Norway.
2Department of Interdisciplinary Health Sciences, Institute of Health and Society, University of Oslo, Oslo, Norway.
Clin Sarcoma Res. 2020 Jan 16;10:2. doi: 10.1186/s13569-019-0124-3. eCollection 2020.
To report on our experience using a simple optional form to facilitate communication on late effects between the patients and the oncologists during outpatient follow-up and to detail on the spectrum of challenges reported by sarcoma survivors.
The form was presented for the patients to complete before their consultation and covered topics related to late effects and unmet needs that the patient wished to discuss with the medical personnel. Logistic regression analysis examined how the distribution of the topics varied with age, gender, diagnosis and type of treatment received.
The form was manageable in a busy outpatient clinic. Of the 265 patients that received the form, 236 (89%) returned it. Patients in a palliative setting and those with other diagnosis than bone sarcoma (BS) and soft-tissue sarcoma (STS) were excluded for subsequent analyses. The final study-cohort comprised 160 patients, 54 (34%) with BS and 106 (66%) with STS. Among these, 140 (88%) had late-effect topics they wanted to discuss with their oncologist. Fatigue was raised by 39% of the patients, pain by 29% and impaired mobility by 23%. BS patients raised fatigue more often (< 0.005) than those with STS. Patients who had undergone multimodal treatment with chemotherapy raised fatigue more frequently ( < 0.001) than those who had only undergone surgery, radiotherapy or both.
A simple form on the long-term consequences of sarcoma treatment achieved a high response rate, was feasible to use in an outpatient clinic and facilitated communication on these issues. Fatigue was the most frequent topic raised and it was raised significantly more often in patients who had undergone chemotherapy.
报告我们使用一种简单的可选表格来促进门诊随访期间患者与肿瘤学家就远期效应进行沟通的经验，并详细阐述肉瘤幸存者报告的一系列挑战。
在患者就诊前提供该表格供其填写，内容涵盖与远期效应及患者希望与医务人员讨论的未满足需求相关的主题。逻辑回归分析检验了这些主题的分布如何随年龄、性别、诊断和所接受的治疗类型而变化。
该表格在繁忙的门诊环境中易于管理。在收到表格的265名患者中，236名（89%）返还了表格。后续分析排除了处于姑息治疗阶段的患者以及诊断不是骨肉瘤（BS）和软组织肉瘤（STS）的患者。最终的研究队列包括160名患者，其中54名（34%）为骨肉瘤患者，106名（66%）为软组织肉瘤患者。在这些患者中，140名（88%）有他们想与肿瘤学家讨论的远期效应主题。39%的患者提到疲劳，29%提到疼痛，23%提到活动能力受损。骨肉瘤患者比软组织肉瘤患者更常提到疲劳（<0.005）。接受化疗的多模式治疗的患者比仅接受手术、放疗或两者的患者更频繁地提到疲劳（<0.001）。
一份关于肉瘤治疗长期后果的简单表格获得了较高的回复率，在门诊使用是可行的，并促进了关于这些问题的沟通。疲劳是最常提到的主题，并且接受化疗的患者更频繁地提到疲劳。
